BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29848919)

  • 21. Deep learning for image classification between primary central nervous system lymphoma and glioblastoma in corpus callosal tumors.
    Jaruenpunyasak J; Duangsoithong R; Tunthanathip T
    J Neurosci Rural Pract; 2023; 14(3):470-476. PubMed ID: 37692824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival duration.
    Huntoon K; Makary MS; Shah VS; Aquino A; Pandya V; Giglio P; Slone HW; Elder JB
    Neuroradiol J; 2023 Aug; 36(4):479-485. PubMed ID: 36715098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification of brain lesions using a machine learning approach with cross-sectional ADC value dynamics.
    Solar P; Valekova H; Marcon P; Mikulka J; Barak M; Hendrych M; Stransky M; Siruckova K; Kostial M; Holikova K; Brychta J; Jancalek R
    Sci Rep; 2023 Jul; 13(1):11459. PubMed ID: 37454179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative Apparent Diffusion Coefficient of Peritumoral Lesion Associate with Recurrence in Patients with Glioblastoma.
    Matsuda K; Kokubo Y; Kanemura Y; Kanoto M; Sonoda Y
    Neurol Med Chir (Tokyo); 2022 Jan; 62(1):28-34. PubMed ID: 34707068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of multiparametric MRI in reducing diagnostic uncertainty for primary central nervous system lymphoma.
    Goel A; Flintham R; Pohl U; Nagaraju S; Meade S; Sanghera P; Benghiat H; Ughratdar I; Wykes V; Sawlani V
    World Neurosurg; 2024 May; ():. PubMed ID: 38740086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balanced transformer: efficient classification of glioblastoma and primary central nervous system lymphoma.
    Wang S; Wu J; Chen M; Huang S; Huang Q
    Phys Med Biol; 2024 Feb; 69(4):. PubMed ID: 38232389
    [No Abstract]   [Full Text] [Related]  

  • 27. Fully automated MR-based virtual biopsy of primary CNS lymphomas.
    Parmar V; Haubold J; Salhöfer L; Meetschen M; Wrede K; Glas M; Guberina M; Blau T; Bos D; Kureishi A; Hosch R; Nensa F; Forsting M; Deuschl C; Umutlu L
    Neurooncol Adv; 2024; 6(1):vdae022. PubMed ID: 38516329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The many faces of glioblastoma: Pictorial review of atypical imaging features.
    Khandwala K; Mubarak F; Minhas K
    Neuroradiol J; 2021 Feb; 34(1):33-41. PubMed ID: 33081585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric magnetic resonance imaging discerns glioblastoma immune microenvironmental heterogeneity.
    Kersch CN; Muldoon LL; Claunch CJ; Fu R; Schwartz D; Cha S; Starkey J; Neuwelt EA; Barajas RF
    Neuroradiol J; 2023 Jun; ():19714009231163560. PubMed ID: 37306690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we distinguish atypical primary brain lymphoma from glioblastoma multiforme by looking at the non-enhancing tumor?
    Fushimi Y; Nakajima S
    Eur Radiol; 2023 Aug; 33(8):5355-5356. PubMed ID: 37212848
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial for: "Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging".
    Boutry S; Laurent S; Burtea C
    J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38091345
    [No Abstract]   [Full Text] [Related]  

  • 32. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
    J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature.
    Yang X; Deng X; Wu M; Chen SW; Jiang M; Long L; Chen BT
    Insights Imaging; 2024 Feb; 15(1):40. PubMed ID: 38353902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of glioblastoma and primary central nervous system lymphomas using multiparametric diffusion and perfusion magnetic resonance imaging.
    Hung ND; Anh NN; Minh ND; Huyen DK; Duc NM
    Biomed Rep; 2023 Nov; 19(5):82. PubMed ID: 37881606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary central nervous system lymphoma.
    Ferreri AJM; Calimeri T; Cwynarski K; Dietrich J; Grommes C; Hoang-Xuan K; Hu LS; Illerhaus G; Nayak L; Ponzoni M; Batchelor TT
    Nat Rev Dis Primers; 2023 Jun; 9(1):29. PubMed ID: 37322012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study.
    Feng A; Li L; Huang T; Li S; He N; Huang L; Zeng M; Lyu J
    Heliyon; 2023 Apr; 9(4):e15150. PubMed ID: 37095995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of the Current Status and Quality of Radiomics for Glioma Differential Diagnosis.
    Brancato V; Cerrone M; Lavitrano M; Salvatore M; Cavaliere C
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
    Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK
    Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine Learning in Differentiating Gliomas from Primary CNS Lymphomas: A Systematic Review, Reporting Quality, and Risk of Bias Assessment.
    Cassinelli Petersen GI; Shatalov J; Verma T; Brim WR; Subramanian H; Brackett A; Bahar RC; Merkaj S; Zeevi T; Staib LH; Cui J; Omuro A; Bronen RA; Malhotra A; Aboian MS
    AJNR Am J Neuroradiol; 2022 Apr; 43(4):526-533. PubMed ID: 35361577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma.
    MacIver CL; Busaidi AA; Ganeshan B; Maynard JA; Wastling S; Hyare H; Brandner S; Markus JE; Lewis MA; Groves AM; Cwynarski K; Thust SC
    J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.